Indications and uses
for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
motion sickness
- Manufacturer
- Strategic Sourcing Services, LLC (Health Mart) | LNK International, Inc.
- Effective date
- 2025-04-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 13
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:39:49
Label at a glance#
Productmotion sickness
Active ingredientDIMENHYDRINATE
Label structure9 sections
Dosage and administration
to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years and over 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years ½ tablet every 6-8 hours; ...
Storage and handling
each tablet contains: calcium 35 mg TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) protect from moisture see end flap for expiration date and lot number
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient (in each tablet)
Dimenhydrinate 50 mg
Purpose
Antiemetic
Uses
for prevention and treatment of these symptoms associated with motion sickness:
- nausea
- vomiting
- dizziness
Warnings
Do not use
for children under 2 years of age unless directed by a doctor.
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
Ask a doctor or pharmacist before use if you are
taking sedatives or tranquilizers.
When using this product
- marked drowsiness may occur
- alcohol, sedatives, and tranquilizers may increase drowsiness
- use caution when driving a motor vehicle or operating machinery
- avoid alcoholic beverages
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
| adults and children 12 years and over | 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor |
| children 6 to under 12 years | ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor |
| children 2 to under 6 years | ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor |
Other information
- each tablet contains: calcium 35 mg
- TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
- store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
- protect from moisture
- see end flap for expiration date and lot number
Inactive ingredients
croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
Questions or comments?
1-800-426-9391
Principal display panel
Health Mart®
NDC 62011-0341-1
Compare to Dramamine® Original Formula
active ingredient*
ORIGINAL FORMULA
Motion Sickness
Dimenhydrinate 50 mg
Antiemetic
Prevents Nausea, Vomiting & Dizziness
for Children & Adults
Actual Size
12 Tablets
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS
OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR
SHOWS ANY SIGNS OF TAMPERING
*This product is not manufactured or distributed by Medtech Products
Inc., owner of the registered trademark Dramamine® Original Formula.
50844 REV0518B19802
McKESSON
Distributed by McKesson
6555 State Highway 161
Irving, TX 75039
healthmart.com
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62011-0341 | MOTION SICKNESS (DIMENHYDRINATE) TABLET [STRATEGIC SOURCING SERVICES, LLC (HEALTH MART)] | 13 | Legacy NDC | 20250411_60fef11b-75df-450c-a3e7-b70c88e65ed3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62011-0341-1 | EA - Each | 62011-0341 | 028eb17d-304b-41a2-a58d-0e5bb9b93dba | 1 | 2017-06-15 |
Products#
Every source-derived product name is available through these pages.
- motion sickness
- dimenhydrinate
- DIPHENHYDRAMINE
- 8-CHLOROTHEOPHYLLINE
- CROSCARMELLOSE SODIUM
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE
- SILICON DIOXIDE
- STEARIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62011-0341 | 62011-0341-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMENHYDRINATE | JB937PER5C | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 58f2bef0-ecef-4266-af16-482a318a645a | 60fef11b-75df-450c-a3e7-b70c88e65ed3 | 2025-04-10 | Warnings | 58f2bef0-ecef-4266-af16-482a318a645a 60fef11b-75df-450c-a3e7-b70c88e65ed3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.